|
|
|
|
|
|
|
|
open access
To the Editor:
The study by Daniels et al1 focused on women with high-grade serous ovarian cancer and showed that carrier probabilities provided by risk prediction
model BRCAPRO2 are too low among low-risk patients. This important observation agrees with earlier reports, including probands with both
ovarian and breast cancers,2
in which the ratio of observed to expected cases (O/E) in low-risk
groups was substantially greater than one. As genetic
testing becomes more affordable and appropriately
broadens to segments of the population who are at lower prior risk, this
limitation deserves serious consideration........
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.